**Core Concept**
ER-positive status in breast cancer (Ca Breast) refers to the presence of estrogen receptors on the surface of cancer cells. This indicates that the cancer cells can be stimulated to grow by the hormone estrogen.

**Why the Correct Answer is Right**
ER-positive breast cancer cells have estrogen receptors (ER) that bind to estrogen, leading to the activation of the estrogen receptor pathway. This pathway promotes cell proliferation and survival. ER-positive breast cancer is more common in postmenopausal women and is often treated with hormone therapy that blocks estrogen production or blocks estrogen receptors. The presence of ER-positive receptors is a critical factor in determining the treatment plan for breast cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as ER-negative status is not a characteristic of the correct answer.
**Option B:** This option is incorrect as HER2-positive status refers to the overexpression of the HER2 protein on the surface of cancer cells, which is a different prognostic factor than ER-positive status.
**Option C:** This option is incorrect as triple-negative breast cancer refers to breast cancer that lacks estrogen receptors, progesterone receptors, and excess HER2 protein, which is a different subtype of breast cancer than ER-positive breast cancer.

**Clinical Pearl / High-Yield Fact**
ER-positive status is a strong predictor of response to hormone therapy in breast cancer. Patients with ER-positive breast cancer are more likely to benefit from hormone therapy, which can include tamoxifen or aromatase inhibitors.

**Correct Answer: D. ER-positive status in Ca Breast indicates the presence of estrogen receptors on the surface of cancer cells.**